Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Risk Anal ; 18(3): 283-91, 1998 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-9664724

RESUMEN

This paper presents estimates of daily average per capita fish consumption by age and gender for the 48 conterminous states. The estimated consumption rates are reported for three fish habitats: freshwater/estuarine fish, marine fish, and all fish. The estimates were generated from the combined 1989, 1990, and 1991 Continuing Survey of Food Intake by Individuals (CSFII), a national food consumption survey conducted by the United States Department of Agriculture (USDA). Point and interval estimates of per capita fish consumption were generated from the empirical distribution of daily average per capita consumption. The point estimates include the mean, 50th, 75th, 90th, 95th, and 99th percentiles. Ninety percent confidence intervals are provided for the estimated mean and 90% bootstrap intervals are provided for percentile estimates. Information in a recipe file provided by USDA was used to calculate the amount of fish in recipes which contain fish. The estimated consumption rates are based on the weight of fish in its prepared or "as consumed" condition. The estimated mean consumption rate for all fish for the U.S. population of the 48 conterminous states was 15.65 grams/person/day (C.I.:14.67-16.63) of which 4.71 grams/person/day (C.I.:4.17-5.25) was freshwater/estuarine fish and 10.94 grams/person/day (C.I.:10.14-11.73) was marine fish.


Asunto(s)
Ingestión de Alimentos , Peces , Adolescente , Adulto , Animales , Recolección de Datos , Femenino , Agua Dulce , Humanos , Masculino , Persona de Mediana Edad , Medición de Riesgo , Agua de Mar , Mariscos , Estados Unidos , Contaminantes Químicos del Agua/toxicidad
2.
Environ Monit Assess ; 13(2-3): 129-48, 1989 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24243169

RESUMEN

This paper describes the process for developing regulations limiting the discharge of pollutants from industrial sources into the waters of the United States. The process includies and surveys of the industry to define products, processes, wastewater sources and characteristics, appropriate subcategorization and control technologies in use. Limitations on the amounts of pollutants that may be discharged in treated wastewater are based on statistical analysis of physical and chemical analytical data characterizing the performance capability of technologies in use in the industry. A general discussion of the statistical approach employed is provided along with some examples based on work performed to support recently promulgated regulations. The determination of regulatory discharge limitations, based on estimates of percentiles of lognormal distributions of measured pollutant concentrations in treated wastewater, is presented. Modifications to account for different averaging periods and detection limit observations are discussed.

3.
Arch Intern Med ; 144(8): 1677-9, 1984 08.
Artículo en Inglés | MEDLINE | ID: mdl-6466024

RESUMEN

Fever, lymphadenopathy, exfoliative dermatitis, and evidence of drug-induced liver injury developed in a 16-year-old girl three weeks after beginning therapy with phenytoin and phenobarbital. This clinical syndrome can be caused by either of these structurally related drugs but has been more frequently attributed to phenytoin. In vitro studies disclosed marked reactivity of this patient's lymphocytes to concentrations of both drugs, which encompassed their measured serum levels. The demonstration of dual reactivity raises concerns about continuing administration of phenobarbital during an apparent phenytoin-induced reaction. Whether this potential risk is greater than the risk of stopping all anticonvulsant medications in a patient with a seizure disorder is not known and remains to be established.


Asunto(s)
Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Hipersensibilidad a las Drogas/inmunología , Fenobarbital/efectos adversos , Fenitoína/efectos adversos , Adolescente , Enfermedad Hepática Inducida por Sustancias y Drogas/inmunología , Reacciones Cruzadas , Femenino , Humanos , Activación de Linfocitos/efectos de los fármacos , Linfocitos/efectos de los fármacos , Fenobarbital/farmacología , Fenitoína/farmacología
5.
J Air Pollut Control Assoc ; 23(11): 973, 1973 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-4756884
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA